–
(AFP) .- The laboratories Pfizer and BioNTech jointly announced Thursday that they would seek regulatory clearance for a third dose of their vaccine.a against COVID-19.
“The companies hope to publish more definitive data soon, as well as in a peer-reviewed journal, and plan to submit the data to the FDA. (US Food and Drug Agency), the EMA (European Medicines Agency) and other regulatory authorities in the coming weeks, “said a statement.